Live antiviral News

Live antiviral news coverage of developments with the latest updates. Stay on top of latest antiviral news stories and find out what just happened, what is going on with antiviral. The latest real-time news updates and headlines on antiviral
Genetic ancestry shapes immune response to influenza virus
Biotron’s BIT225 effective against Covid in animal study
Preparing anti-Covid agent EIDD-2801 by practical and scalable approach, and quick evaluation via machine learning
How genetic differences leave immune cells at disadvantage
Plant-derived antiviral drug is effective in blocking highly infectious SARS-CoV-2 Delta variant, say scientists
Statement of President Joe Biden on Pfizer’s COVID- 19 Antiviral Treatment
Pfizer Announces Retirement of Chief Financial Officer Frank D’Amelio
Pfizer and Medicines Patent Pool Sign Licensing Agreement for Covid Oral Antiviral Treatment Candidate to Expand Access
Increased use of higher-cost medicines continues to put pressure on Canadian public drug plans
Gates Foundation funding for University to develop low cost manufacturing route to promising Covid therapy Molnupiravir
Quick, high-yield synthesis of molnupiravir, an investigational COVID antiviral pill
Finding new purpose for old drugs: Researchers have found promising drugs for Covid
Potential new treatment for Covid identified
Emory supports Medicines Patent Pool and Merck license agreement for molnupiravir to treat Covid
WHO-Unitaid statement on MPP licensing agreement for molnupiravir
Researchers uncover how novel coronavirus escapes cell’s antiviral defenses
Mechanism underlying emergence of virus variants unraveled
Lactoferrin supplements could aid in recovery of COVID19
Noninfectious versions of SARS-CoV-2 provide powerful research tools
Metabolic restoration in HIV-infected patients as therapeutic approach
Scientists discover highly potent antibody against SARS-CoV-2
Researchers Propose Novel Mechanism of Anthraquinone Ring Opening
Rare feat: Material protects against both biological and chemical threats
AGILE Covid drug testing platform opens new trial in South Africa
KU Leuven develops very potent antiviral against dengue
TGA grants provisional determination to Pfizer Australia’s Covid treatment PF-07321332 + ritonavir
Australia secures access to additional Covid treatment
Government must buy Covid treatments now
Liquid Metal Coating Creates Effective Antiviral, Antimicrobial Fabric
Molecular explanation for sensor that protects against severe Covid
Researchers identify mutations of Delta, Delta Plus variants
As schools reopen, Oregon virus surveillance project helps families navigate complex time
Watching Covid spread in animal models in real time
Pfizer Starts Global Phase 2/3 EPIC-PEP Study of Novel Covid Oral Antiviral Candidate for Post-Exposure Prophylaxis
NIAID Scientists Find Key to Hepatitis C Entry into Cells
SFU study finds older adults have weaker immune responses from Covid vaccine
Funding boost for research into Covid treatments
Gout medicine could also battle Covid
Medicine that treats gout could also battle Covid
Subscription-based payment models may improve access to hepatitis C medications
Making Cells Talk Again
RedHill Biopharma’s Opaganib demonstrates strong inhibition of Covid delta variant
TGA grants provisional determination to Celltrion Healthcare Australia Pty Ltd’s antiviral Covid treatment regdanvimab
Risks of importing Ivermectin for treatment of Covid
Discovery of fusilli-shaped polymers through new kind of click chemistry
Molecular mechanisms of corona drug candidate Molnupiravir unraveled
TGA grants provisional determination to Merck Sharp & Dohme’s antiviral Covid treatment Molnupiravir
Studies uncover details of “exhausted” immune cells in patients with chronic infections